Trehalose: From Research Compound to Clinical Candidate for Parkinson’s Disease

Time: 4:00 pm
day: Conference Day One PM

Details:

  • Overview of trehalose and its effects as a modulator of autophagy
  • Pharmacokinetics and brain penetration of trehalose in rodents and non-human primates
  • Lowering the therapeutic dose of trehalose and moving into clinical development

Speakers: